Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 32% ± 15% | |
peripheral blood | 15 studies | 22% ± 8% | |
brain | 11 studies | 32% ± 13% | |
intestine | 9 studies | 29% ± 11% | |
kidney | 8 studies | 29% ± 8% | |
liver | 6 studies | 32% ± 13% | |
heart | 5 studies | 29% ± 6% | |
breast | 5 studies | 30% ± 5% | |
bone marrow | 4 studies | 28% ± 9% | |
uterus | 4 studies | 41% ± 17% | |
prostate | 4 studies | 32% ± 8% | |
adipose | 4 studies | 24% ± 4% | |
pancreas | 3 studies | 26% ± 7% | |
placenta | 3 studies | 36% ± 11% | |
eye | 3 studies | 34% ± 14% | |
esophagus | 3 studies | 35% ± 15% | |
skin | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 32625.77 | 1445 / 1445 | 100% | 585.96 | 183 / 183 |
ovary | 100% | 18417.58 | 180 / 180 | 100% | 475.31 | 430 / 430 |
uterus | 100% | 45609.76 | 170 / 170 | 100% | 388.65 | 458 / 459 |
stomach | 100% | 18215.06 | 359 / 359 | 100% | 539.16 | 285 / 286 |
intestine | 100% | 26612.38 | 966 / 966 | 100% | 483.25 | 525 / 527 |
skin | 100% | 31409.12 | 1808 / 1809 | 99% | 402.66 | 469 / 472 |
bladder | 100% | 27601.24 | 21 / 21 | 99% | 354.73 | 499 / 504 |
breast | 100% | 29632.76 | 459 / 459 | 99% | 302.85 | 1106 / 1118 |
kidney | 100% | 27244.18 | 89 / 89 | 99% | 272.05 | 888 / 901 |
lung | 100% | 32907.78 | 577 / 578 | 99% | 347.98 | 1139 / 1155 |
prostate | 100% | 22263.58 | 245 / 245 | 98% | 193.95 | 492 / 502 |
thymus | 100% | 20943.18 | 652 / 653 | 98% | 283.44 | 593 / 605 |
adrenal gland | 100% | 28859.22 | 258 / 258 | 94% | 178.75 | 217 / 230 |
pancreas | 93% | 10235.80 | 306 / 328 | 98% | 389.84 | 175 / 178 |
brain | 89% | 8376.76 | 2353 / 2642 | 96% | 139.94 | 678 / 705 |
liver | 84% | 7604.38 | 189 / 226 | 90% | 149.88 | 367 / 406 |
adipose | 100% | 31246.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 77896.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 21551.32 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 345.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 265.29 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 278.56 | 79 / 80 |
heart | 93% | 10295.93 | 799 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 11434.30 | 838 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 120.85 | 25 / 29 |
muscle | 50% | 3871.29 | 402 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035357 | Biological process | peroxisome proliferator activated receptor signaling pathway |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0055001 | Biological process | muscle cell development |
GO_0030050 | Biological process | vesicle transport along actin filament |
GO_0032417 | Biological process | positive regulation of sodium:proton antiporter activity |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1900025 | Biological process | negative regulation of substrate adhesion-dependent cell spreading |
GO_0015031 | Biological process | protein transport |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030018 | Cellular component | Z disc |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0005925 | Cellular component | focal adhesion |
GO_0001725 | Cellular component | stress fiber |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0098871 | Cellular component | postsynaptic actin cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0031143 | Cellular component | pseudopodium |
GO_0030054 | Cellular component | cell junction |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0001882 | Molecular function | nucleoside binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005178 | Molecular function | integrin binding |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0003723 | Molecular function | RNA binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | ACTN4 |
Protein name | Actinin alpha 4 isoform 2 Alpha-actinin-4 (Non-muscle alpha-actinin 4) Actinin alpha 4 isoform 4 ACTN4 protein |
Synonyms | hCG_1996371 |
Description | FUNCTION: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation . Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (By similarity). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA . . |
Accessions | ENST00000634960.2 [O43707-1] Q96BG6 ENST00000424234.7 H7C144 ENST00000440400.3 ENST00000589528.1 ENST00000697712.1 A0A0S2Z3G1 ENST00000634692.1 [O43707-2] ENST00000390009.7 [O43707-2] K7EP19 O43707 A0A8V8TL71 A0A0S2Z3G9 A0A0S2Z3X3 F5GXS2 ENST00000252699.7 [O43707-1] A0A0S2Z3C0 |